Pharmaceutical Market Europe • January 2023 • 3

COMMENT

Meeting healthcare’s rising challenges

Happy New Year and welcome to our first issue of 2023!

In this issue, our cover article by Danny Buckland focuses on meeting healthcare’s rising challenges and the use of digital innovation to discover novel therapies and ensure scientific advances achieve their potential.

As Danny says, there are ‘an overwhelming set of challenges to treat increasingly ageing populations that have multiple co-morbidities while, at the same time, healthcare systems are struggling under extreme financial and organisational pressures.

‘High-level demands mean traditional approaches are no longer as effective, as the global number of people over 60 is expected to double to 22% over the next 25 years, by which time 80% of older people will be living in low- and middle-income countries.

‘Digital innovation is already playing a significant role in diagnostics, remote patient monitoring, supercharging electronic records, predictive analysis and enabling people to play a greater role in their health.’ But, as Danny goes on to say, there are also questions about the need for high-grade security and privacy controls. Read more on page 26.

Also in this month’s issue, we take a look at the ASH Congress that took place in New Orleans in the US in December 2022 and the five trends driving changes in haematology. Turn to page 16 to find out more.

Looking ahead, our February issue will focus on the impact of COVID-19 on healthcare.

The resounding impact of measures taken to both mitigate infection risks and redirect the priorities of the healthcare system, which included the postponement of non-urgent medical care such as elective surgeries and routine screenings, are still being seen today as the healthcare system continues to struggle to tackle the COVID-19 backlog and its associated consequences.

If you would like to make your voice heard on these topics, please get in touch at sales@pmlive.com

I hope you enjoy this issue!

Image

Iona Everson
Group Managing Editor

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson

Journalist/editorial assistant
Emily Kimber


Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2023 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image